https://en.bioecon.ru/companies/wuxi-biologics/Recent content in Wuxi-Biologics on BioeconHugoen-USSat, 11 Jul 2026 14:19:14 +0700https://en.bioecon.ru/technology/bioproduction-cdmo-cmo/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/bioproduction-cdmo-cmo/Contract development and manufacturing organizations providing specialized infrastructure for advanced biopharmaceuticals.https://en.bioecon.ru/technology/local-manufacturing-for-market-access/Wed, 24 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/local-manufacturing-for-market-access/Contract development, technology-transfer and local-build services that establish in-country or regional biomanufacturing so a biologic or vaccine qualifies for market access, procurement preference and supply security in target jurisdictions.https://en.bioecon.ru/technology/biologics/Thu, 18 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/biologics/Biologics — monoclonal antibodies, ADCs, CAR-T and gene therapy — are the largest and fastest-growing drug class, built on a reproducible cell-line platform at 2–10 g/L titers.